Latest Loan Facility News

Hammer Metals is set to terminate its agreement with Larvotto Resources after Larvotto declined to match a superior acquisition offer from Austral Resources. The company plans to finalise a deal with Austral, triggering contractual payments to Larvotto.

CAR Group Limited reported a 14% increase in net profit after tax to AUD 332.4 million for FY26, driven by strong revenue growth and AI innovation across its global vehicle marketplaces.

Altamin Limited has locked in a $2 million unsecured loan facility from its major shareholder Victor Smorgon Group, providing non-dilutive funding to advance its Lazio and Gorno projects and shore up working capital.

Dimerix CEO Dr Nina Webster detailed the company’s geographic and product diversification at the Bioshares Summit, spotlighting the commercial potential of DMX-200 and the newly acquired Phase 2 asset DMX-652 targeting acute kidney injury.

Atomos Limited has turned a corner in FY26, posting over 20% sales growth to around $40 million and swinging to EBITDA profitability after prior losses, boosted by new product launches and the strategic acquisition of Flanders Scientific.

Comet Ridge has raised $40 million through a placement and $875,750 via a share purchase plan to fund the acquisition of Santos’ remaining stake in the Mahalo Gas Project and progress development activities.

Echelon Resources has finalised its divestment of Cue Energy shares, boosting cash and cutting debt, while progressing key drilling and gas supply agreements.

Nutritional Growth Solutions (ASX: NGS) has secured a $2.5 million placement and moved closer to acquiring Sprout Organic, aiming to boost revenue and cut costs amid improved cash flow.

ClearVue Technologies bolstered its balance sheet with a A$6 million capital raise while landing high-profile projects including Canva’s Sydney HQ and its first European contract in Cyprus. The company also advanced international expansion and achieved key certifications confirming product durability and safety.

Minbos Resources has appointed a new CEO, secured key funding tranches, and progressed construction at its flagship Cabinda Phosphate Project, targeting plant inauguration by December 2026.

Dimerix Limited (ASX: DXB) has inked its fifth regional licensing agreement with Everest Medicines, boosting potential milestone payments to A$1.9 billion and expanded its kidney disease pipeline through the acquisition of DMX-652. The Phase 3 ACTION3 trial for DMX-200 remains statistically robust, with funding secured to advance both clinical programs.

HITIQ Limited has fortified its financial position through a $1.4 million placement and secured milestone-based Victorian Government funding, accelerating its manufacturing expansion and commercial growth in concussion management technology.